FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2136830517> ?p ?o ?g. }

• W2136830517 endingPage "276" @default.
• W2136830517 startingPage "271" @default.
• W2136830517 abstract "<h3>BACKGROUND AND PURPOSE:</h3> The PED is an FDS designed for the treatment of intracranial aneurysms. Data regarding the use of this device in acute or subacute aSAH is limited to a few case reports or small series. We aimed to demonstrate the feasibility of using an FDS, the PED, for the treatment of ruptured intracranial aneurysms with challenging morphologies. <h3>MATERIALS AND METHODS:</h3> We conducted a retrospective review of all known patients treated with the PED for aSAH at 4 institutions between June 2008 and January 2012. Pertinent clinical and radiologic information was submitted by individual centers for central collation. The decision to treat with the PED was made on a case-by-case basis by a multidisciplinary team under compassionate use. <h3>RESULTS:</h3> Twenty patients (15 women; median age, 54.5 years; IQR, 8.0 years) were found. There were 8 blister, 8 dissecting or dysplastic, 2 saccular, and 2 giant aneurysms. Median time to treatment was 4 days (range, 1–90 days; IQR, 12.75 days) from rupture. Three patients had previous failed treatment. Procedure-related symptomatic morbidity and mortality were 15%, with 1 (5%) procedure-related death. Two patients died relative to medical complications, and 1 patient was lost to follow-up. Sixteen patients were available for follow-up, 81% had a GOS of 5, and 13% had a GOS of 4 attributed to a poorer initial clinical presentation. One patient died of urosepsis at 4 months. Occlusion rates were 75% and 94% at 6 months and 12 months, respectively. There were 3 delayed complications (1 silent perforator infarct, 2 moderate asymptomatic in-stent stenoses). No symptomatic delayed complications or rehemorrhages occurred. <h3>CONCLUSIONS:</h3> The FDS may be a feasible treatment option in the acute or subacute setting of selected ruptured aneurysms, especially blister aneurysms. Ruptured giant aneurysms remain challenging for both surgical and endovascular techniques; at this stage, FDSs should be used with caution in this aneurysm subtype." @default.
• W2136830517 created "2016-06-24" @default.
• W2136830517 creator A5031270256 @default.
• W2136830517 creator A5053607760 @default.
• W2136830517 creator A5054313954 @default.
• W2136830517 creator A5056260292 @default.
• W2136830517 creator A5060454556 @default.
• W2136830517 creator A5062819062 @default.
• W2136830517 creator A5074675567 @default.
• W2136830517 creator A5075056586 @default.
• W2136830517 date "2012-10-11" @default.
• W2136830517 modified "2023-10-16" @default.
• W2136830517 title "Pipeline Embolization Device in Aneurysmal Subarachnoid Hemorrhage" @default.
• W2136830517 cites W1601678575 @default.
• W2136830517 cites W1604258286 @default.
• W2136830517 cites W1794682851 @default.
• W2136830517 cites W1966266496 @default.
• W2136830517 cites W1974542285 @default.
• W2136830517 cites W1981532173 @default.
• W2136830517 cites W1997472898 @default.
• W2136830517 cites W2014129419 @default.
• W2136830517 cites W2017374213 @default.
• W2136830517 cites W2020696467 @default.
• W2136830517 cites W2035313252 @default.
• W2136830517 cites W2037996328 @default.
• W2136830517 cites W2048905734 @default.
• W2136830517 cites W2049457167 @default.
• W2136830517 cites W2051241277 @default.
• W2136830517 cites W2059947861 @default.
• W2136830517 cites W2075726719 @default.
• W2136830517 cites W2077896345 @default.
• W2136830517 cites W2085944854 @default.
• W2136830517 cites W2097363132 @default.
• W2136830517 cites W2099573833 @default.
• W2136830517 cites W2099809493 @default.
• W2136830517 cites W2105965310 @default.
• W2136830517 cites W2108876549 @default.
• W2136830517 cites W2108972511 @default.
• W2136830517 cites W2112804733 @default.
• W2136830517 cites W2113516725 @default.
• W2136830517 cites W2116318228 @default.
• W2136830517 cites W2118145123 @default.
• W2136830517 cites W2120398741 @default.
• W2136830517 cites W2131923323 @default.
• W2136830517 cites W2132175468 @default.
• W2136830517 cites W2134486404 @default.
• W2136830517 cites W2135045058 @default.
• W2136830517 cites W2136308178 @default.
• W2136830517 cites W2139585136 @default.
• W2136830517 cites W2145121306 @default.
• W2136830517 cites W2146874970 @default.
• W2136830517 cites W2148122420 @default.
• W2136830517 cites W2148226141 @default.
• W2136830517 cites W2150433179 @default.
• W2136830517 cites W2152159948 @default.
• W2136830517 cites W2152454049 @default.
• W2136830517 cites W2153528438 @default.
• W2136830517 cites W2166267105 @default.
• W2136830517 cites W3175098783 @default.
• W2136830517 cites W4235429873 @default.
• W2136830517 cites W4236859774 @default.
• W2136830517 cites W4250302808 @default.
• W2136830517 doi "https://doi.org/10.3174/ajnr.a3380" @default.
• W2136830517 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7965105" @default.
• W2136830517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23064594" @default.
• W2136830517 hasPublicationYear "2012" @default.
• W2136830517 type Work @default.
• W2136830517 sameAs 2136830517 @default.
• W2136830517 citedByCount "79" @default.
• W2136830517 countsByYear W21368305172013 @default.
• W2136830517 countsByYear W21368305172014 @default.
• W2136830517 countsByYear W21368305172015 @default.
• W2136830517 countsByYear W21368305172016 @default.
• W2136830517 countsByYear W21368305172017 @default.
• W2136830517 countsByYear W21368305172018 @default.
• W2136830517 countsByYear W21368305172019 @default.
• W2136830517 countsByYear W21368305172020 @default.
• W2136830517 countsByYear W21368305172021 @default.
• W2136830517 countsByYear W21368305172022 @default.
• W2136830517 countsByYear W21368305172023 @default.
• W2136830517 crossrefType "journal-article" @default.
• W2136830517 hasAuthorship W2136830517A5031270256 @default.
• W2136830517 hasAuthorship W2136830517A5053607760 @default.
• W2136830517 hasAuthorship W2136830517A5054313954 @default.
• W2136830517 hasAuthorship W2136830517A5056260292 @default.
• W2136830517 hasAuthorship W2136830517A5060454556 @default.
• W2136830517 hasAuthorship W2136830517A5062819062 @default.
• W2136830517 hasAuthorship W2136830517A5074675567 @default.
• W2136830517 hasAuthorship W2136830517A5075056586 @default.
• W2136830517 hasBestOaLocation W21368305171 @default.
• W2136830517 hasConcept C141071460 @default.
• W2136830517 hasConcept C167135981 @default.
• W2136830517 hasConcept C2776035437 @default.
• W2136830517 hasConcept C2776098176 @default.
• W2136830517 hasConcept C2777601897 @default.
• W2136830517 hasConcept C2777736543 @default.
• W2136830517 hasConcept C71924100 @default.
• W2136830517 hasConceptScore W2136830517C141071460 @default.

• next